Loading the section
Closing prices for 09 October 2026
Next earnings report: 02 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Myriad Genetics, Inc. trades on Nasdaq under the ticker MYGN. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks MYGN has traded between 2.74 $ and 8.59 $. As of 09 October 2026 the price stood 26.84 % of the way from the 52-week low to the high.
Over one year MYGN shares fell 43.59 %; over six months they fell 0.92 %. Volatility over 90 days is 123.38 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.5, below the sector median of 3.9. Price to book is 1.2, below the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 4.18 | 4.40 | 4.15 | 4.31 | 1M |
| 08 October 2026 | 4.24 | 4.26 | 4.05 | 4.20 | 2M |
| 07 October 2026 | 4.25 | 4.32 | 4.12 | 4.28 | 2M |
| 06 October 2026 | 4.62 | 4.83 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116, US
Myriad Genetics, Inc. reported revenue of 829M $ and a net loss of 400M $ over the last four quarters. Net margin is −48.24 %. Revenue changed by −0.28 % year over year. Earnings per share are −4.31 $. Market capitalisation is 396M $.
MYGN has a return on equity of −118.52 %, below the sector median of −41.68 %. Return on assets is −59.36 %, below the sector median of −32.11 %. Operating margin is −46.91 %, below the sector median of −26.84 %.
| 60M |
| NEOGNeogen Corporation | 11.85 | +1.20 % | 56M |
| QDELQuidelOrtho Corporation | 13.42 | +8.14 % | 20M |
| ACHVAchieve Life Sciences, Inc. | 7.39 | +2.78 % | 12M |
| QCLSQ/C Technologies, Inc. | 0.6300 | −1.10 % | 10M |
| 4.22 |
| 4.28 |
| 2M |
| 05 October 2026 | 4.51 | 4.62 | 4.41 | 4.58 | 3M |
| 02 October 2026 | 4.16 | 4.59 | 4.16 | 4.54 | 2M |
| 01 October 2026 | 4.28 | 4.31 | 4.06 | 4.06 | 2M |
| 30 September 2026 | 4.28 | 4.39 | 4.22 | 4.31 | 2M |
| 29 September 2026 | 4.26 | 4.37 | 4.22 | 4.23 | 2M |
| 28 September 2026 | 4.11 | 4.34 | 4.08 | 4.24 | 1M |
| 25 September 2026 | 4.16 | 4.25 | 4.07 | 4.17 | 2M |
| 24 September 2026 | 4.00 | 4.26 | 3.97 | 4.14 | 2M |
| 23 September 2026 | 4.02 | 4.23 | 3.97 | 4.01 | 2M |
| 22 September 2026 | 3.90 | 4.06 | 3.76 | 4.02 | 2M |
| 21 September 2026 | 3.93 | 4.04 | 3.87 | 4.01 | 2M |
| 18 September 2026 | 4.15 | 4.17 | 3.86 | 3.89 | 4M |
| 17 September 2026 | 3.89 | 4.17 | 3.75 | 4.14 | 3M |
| 16 September 2026 | 3.75 | 4.09 | 3.75 | 3.86 | 2M |
| 15 September 2026 | 3.80 | 3.98 | 3.70 | 3.88 | 5M |
| 14 September 2026 | 3.43 | 3.82 | 3.42 | 3.79 | 3M |